These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9445743)

  • 1. [Indications and prescription of hepatitis A vaccine in Spain. Report of the Spain Association for the Study of the Liver].
    Bruguera M; Buti M; Diago M; García Bengoechea M; Jara P; Pedreira JA; Ruiz Extremera A
    Gastroenterol Hepatol; 1997 Nov; 20(9):467-73. PubMed ID: 9445743
    [No Abstract]   [Full Text] [Related]  

  • 2. [Indications and prescription of hepatitis A vaccine in Spain. Report of the Spanish Association for the Study of the Liver].
    Bruguera M; Buti M; Diago M; García Bengoechea M; Jara P; Pedreira JD; Ruiz Estremera A
    Med Clin (Barc); 1998 Sep; 111(9):341-6. PubMed ID: 9810537
    [No Abstract]   [Full Text] [Related]  

  • 3. [Who in The Netherlands is eligible for immunization with inactivated hepatitis A vaccine?].
    Leentvaar-Kuijpers A
    Ned Tijdschr Geneeskd; 1994 May; 138(19):941-2. PubMed ID: 8196784
    [No Abstract]   [Full Text] [Related]  

  • 4. The value of immunization against hepatitis A.
    Lemon SM; Shapiro CN
    Infect Agents Dis; 1994 Feb; 3(1):38-49. PubMed ID: 7952926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis A vaccine.
    Nalin DR
    J Occup Environ Med; 1996 Dec; 38(12):1200-1. PubMed ID: 8978510
    [No Abstract]   [Full Text] [Related]  

  • 6. WHO position paper on hepatitis A vaccines.
    Can Commun Dis Rep; 2000 Mar; 26(5):33-8. PubMed ID: 10769944
    [No Abstract]   [Full Text] [Related]  

  • 7. Additional potential candidates for hepatitis A vaccination.
    Monkemuller KE
    Am J Gastroenterol; 1996 Aug; 91(8):1670-1. PubMed ID: 8759697
    [No Abstract]   [Full Text] [Related]  

  • 8. Licensure of inactivated hepatitis A vaccine and recommendations for use among international travelers.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1995 Jul; 44(29):559-60. PubMed ID: 7616951
    [No Abstract]   [Full Text] [Related]  

  • 9. Protection of travelers against Hepatitis A viral infection in developing countries.
    Arya SC
    J Travel Med; 1998 Dec; 5(4):228-9. PubMed ID: 9935325
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute hepatitis A in a traveler who had received preexposure inactivated hepatitis A virus vaccine.
    Kurup A; San LM; Yew WS
    Clin Infect Dis; 1999 Jun; 28(6):1324-5. PubMed ID: 10451178
    [No Abstract]   [Full Text] [Related]  

  • 11. [For whom is the hepatitis A vaccination in 1995?].
    Buisson Y
    Gastroenterol Clin Biol; 1995 Oct; 19(10):745-6. PubMed ID: 8566554
    [No Abstract]   [Full Text] [Related]  

  • 12. Statement on immunizing agents for the prevention of hepatitis.
    CMAJ; 1985 Sep; 133(6):581-5. PubMed ID: 3161607
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis A updated.
    Yap I
    Singapore Med J; 1995 Feb; 36(1):23-4. PubMed ID: 7570128
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recommendations for the use of the hepatitis A vaccine in day care centers. Committee on Vaccines of the Spanish Pediatric Society and Spanish Association for the Study of the Liver].
    Gastroenterol Hepatol; 1998; 21(7):346-51. PubMed ID: 9808900
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis A vaccination for sewage workers.
    Donoghue AM; Hancox B
    N Z Med J; 1995 Jun; 108(1001):235-6. PubMed ID: 7603664
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis A: epidemiology and prevention.
    Feinstone SM
    Eur J Gastroenterol Hepatol; 1996 Apr; 8(4):300-5. PubMed ID: 8781894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supplementary statement on hepatitis A prevention.
    Can Commun Dis Rep; 1996 Jan; 22(1):1-3. PubMed ID: 8825660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The success of hepatitis A vaccine.
    Sjogren MH
    Gastroenterology; 1993 Apr; 104(4):1214-6. PubMed ID: 8385043
    [No Abstract]   [Full Text] [Related]  

  • 19. [Characteristics of reactogenic and immunogenic properties of the children's variant of the domestic vaccine, "Gep-A-in-Vak", against hepatitis A].
    Ikoev VN; Gorbunov MA; Maĭdaniuk AG; Karpovich LG; Kalashnikova TV; Bektimirov TA; Karpova EV; Nemtsov IuV; Muntlieva MA; Kriuk NI
    Vopr Virusol; 1999; 44(3):133-6. PubMed ID: 10392439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of hepatitis A in children--implications for hepatitis A vaccine.
    Mittal SK; Rastogi A; Rastogi A; Kumar N; Talukdar B; Kar P
    Trop Gastroenterol; 1998; 19(3):120-1. PubMed ID: 9828714
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.